Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 22242939)

1.

Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.

Lisabeth EM, Fernandez C, Pasquale EB.

Biochemistry. 2012 Feb 21;51(7):1464-75. doi: 10.1021/bi2014079. Epub 2012 Feb 8.

2.

Signals from Eph and ephrin proteins: a developmental tool kit.

Boyd AW, Lackmann M.

Sci STKE. 2001 Dec 11;2001(112):re20. Review.

PMID:
11741094
3.

Dancing with the dead: Eph receptors and their kinase-null partners.

Truitt L, Freywald A.

Biochem Cell Biol. 2011 Apr;89(2):115-29. doi: 10.1139/o10-145. Review.

PMID:
21455264
4.
5.

Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R.

Cancer Metastasis Rev. 2012 Jun;31(1-2):295-321. doi: 10.1007/s10555-012-9346-z. Review.

6.

The role of the Eph-ephrin signalling system in the regulation of developmental patterning.

Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF, Boyd AW.

Int J Dev Biol. 2002;46(4):375-84. Review.

7.

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis.

Dodelet VC, Pasquale EB.

Oncogene. 2000 Nov 20;19(49):5614-9. Review.

8.

The role of ephrins and Eph receptors in cancer.

Surawska H, Ma PC, Salgia R.

Cytokine Growth Factor Rev. 2004 Dec;15(6):419-33. Review.

PMID:
15561600
9.

'Eph'ective signaling: forward, reverse and crosstalk.

Murai KK, Pasquale EB.

J Cell Sci. 2003 Jul 15;116(Pt 14):2823-32. Review.

10.

Autoinhibitory mechanisms in receptor tyrosine kinases.

Hubbard SR.

Front Biosci. 2002 Feb 1;7:d330-40. Review.

PMID:
11815286
11.

Eph-dependent cell-cell adhesion and segregation in development and cancer.

Nievergall E, Lackmann M, Janes PW.

Cell Mol Life Sci. 2012 Jun;69(11):1813-42. doi: 10.1007/s00018-011-0900-6. Epub 2011 Dec 28. Review.

PMID:
22204021
12.

EPH receptors in cancer.

Castaño J, Davalos V, Schwartz S Jr, Arango D.

Histol Histopathol. 2008 Aug;23(8):1011-23. Review.

PMID:
18498077
13.

The role of Eph receptors and ephrin ligands in colorectal cancer.

Herath NI, Boyd AW.

Int J Cancer. 2010 May 1;126(9):2003-11. doi: 10.1002/ijc.25147. Review.

PMID:
20039322
14.

Receptor tyrosine kinases and their activation in melanoma.

Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC.

Pigment Cell Melanoma Res. 2011 Jun;24(3):446-61. doi: 10.1111/j.1755-148X.2011.00836.x. Epub 2011 Mar 3. Review.

PMID:
21320293
15.

Receptor tyrosine kinases: from biology to pathology.

Choura M, Rebaï A.

J Recept Signal Transduct Res. 2011 Dec;31(6):387-94. doi: 10.3109/10799893.2011.625425. Epub 2011 Oct 31. Review.

PMID:
22040163
16.

The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.

Kandouz M.

Cancer Metastasis Rev. 2012 Jun;31(1-2):353-73. doi: 10.1007/s10555-012-9352-1. Review.

PMID:
22549394
17.

The ephrins and Eph receptors in angiogenesis.

Cheng N, Brantley DM, Chen J.

Cytokine Growth Factor Rev. 2002 Feb;13(1):75-85. Review.

PMID:
11750881
18.

Control of cell behaviour by signalling through Eph receptors and ephrins.

Mellitzer G, Xu Q, Wilkinson DG.

Curr Opin Neurobiol. 2000 Jun;10(3):400-8. Review.

PMID:
10851175
19.

Spatial regulation of receptor tyrosine kinases in development and cancer.

Casaletto JB, McClatchey AI.

Nat Rev Cancer. 2012 May 24;12(6):387-400. doi: 10.1038/nrc3277. Review.

20.

Receptor protein tyrosine phosphatases and cancer: new insights from structural biology.

Nikolaienko RM, Agyekum B, Bouyain S.

Cell Adh Migr. 2012 Jul-Aug;6(4):356-64. doi: 10.4161/cam.21242. Epub 2012 Jul 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk